Company: ARAI
Filing Date: 2025-07-15
Form Type: S-1/A
Source: 0001641172-25-019572
Chunk: 10

Company: Arrive AI Inc.
Filing Date: 2025-07-15
Form: S-1/A
Chunk 10
---
 this prospectus represent one hundred percent (100%) of the
company’s currently issued and outstanding common stock, all of such outstanding shares as of the date of this prospectus may
be freely sold upon the effective date of this registration statement. None of such outstanding shares as of the date of this
prospectus and registered herein may be freely sold in reliance on an exemption from registration such as Rule 144 at this time. We
also have 612,107 shares of common stock issuable upon the exercise of options outstanding as of the date of this prospectus
(after giving effect to the Reverse Stock Split). Of these, 96,843 are held by the Registered Shareholders. All the shares of
common stock subject to stock options outstanding and reserved for issuance under our equity incentive plan are registered on Form S-8,
filed with the SEC on June 12, 2025 (the “Plan”), under the Securities Act and such shares are eligible for sale in the public markets,
subject to the limitations applicable to affiliates under Rule 144.

Reverse Stock Split

Our board of directors and our stockholders each
approved the Reverse Stock Split. On November 25, 2024, we filed a certificate of amendment of certificate of incorporation with the
State of Delaware to immediately effect the Reverse Stock Split. All share and per share information in this prospectus are presented
after giving effect to the Reverse Stock Split retrospectively for all periods presented, unless otherwise stated or the context otherwise
requires.

| 3 |

<div align='center'>Summary of Risk Factors</div>

Below is a summary of material factors that make
an investment in our securities speculative or risky. This summary may not address all of the risks and uncertainties that we face. Additional
discussion of the risks and uncertainties summarized in this risk factor summary, as well as other risks and uncertainties that we face,
can be found under the section titled “Risk Factors” in this prospectus. The below summary is qualified in its entirety by
that more complete discussion of such risks and uncertainties. You should carefully consider the risks and uncertainties described under
the section titled “Risk Factors” as part of your evaluation of an investment in our securities:

● Our lack of commercial operations makes
evaluating our business difficult and as result, our securities are considered highly speculative.

● We had negative operating cash flow for
the three months ended March 31, 2025 and 2024, respectively.

● We have not based our financial projections
or valuation on actual